Identification | Back Directory | [Name]
Benzenepropanamide, N-[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)methyl]-2,6-difluoro-β-methyl- | [CAS]
2316782-88-2 | [Synonyms]
AGPS-IN-2i Benzenepropanamide, N-[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)methyl]-2,6-difluoro-β-methyl- | [Molecular Formula]
C18H17F2N3O2 | [MOL File]
2316782-88-2.mol | [Molecular Weight]
345.35 |
Chemical Properties | Back Directory | [Boiling point ]
454.7±45.0 °C(Predicted) | [density ]
1.302±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
12.01±0.30(Predicted) | [color ]
Off-white to light brown |
Hazard Information | Back Directory | [Description]
AGPS-IN-2i is a novel inhibitor of alkylglyceronephosphate synthase (agps), specifically impairing epithelial to mesenchymal transition (emt) by modulating e-cadherin, snail and mmp2 expression levels. |
|
Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Website: |
https://www.chemicalbook.com/ShowSupplierProductsList927327/0.htm |
|